Nitrendipin Al (Nitrendipine)

Nitrendipine selectively blocks L‑type calcium channels in arterial smooth‑muscle cells. By inhibiting calcium influx, it prevents contraction of the vascular smooth muscle, leading to vasodilation, decreased peripheral resistance, and a fall in systolic and diastolic blood pressure.

The dosage of Nitrendipin Al is individualized by the prescribing clinician based on the patient’s blood pressure, response, and tolerability. The prescriber determines the appropriate strength, frequency, and titration schedule in accordance with clinical guidelines.

The safety of nitrendipine in pregnancy has not been established, and it is classified as a pregnancy category unknown. It should be used only if the potential benefit justifies the potential risk to the fetus. Breastfeeding mothers should consult their physician, as the drug may be excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the desired quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Nitrendipin Al belongs to the dihydropyridine calcium‑channel blocker class, which primarily causes arterial vasodilation. Compared with beta‑blockers or ACE inhibitors, it has a more pronounced effect on peripheral resistance and a lower incidence of bronchospasm, but may cause more flushing and peripheral edema. Choice of therapy depends on patient comorbidities and physician judgment.

Nitrendipin Al tablets should be stored at temperatures below 25 °C, in a dry environment, and protected from moisture and direct sunlight. Keep the medication in its original container with the lid tightly closed until use, and discard any tablets that appear discoloured or damaged.

Nitrendipin Al is taken orally, usually with a glass of water. It may be administered with or without food, but consistent intake with respect to meals helps maintain stable plasma concentrations. Patients should follow the prescribing clinician’s instructions regarding timing and any dose adjustments.

Serious adverse reactions, although rare, include severe hypotension, myocardial infarction, hepatic dysfunction, and allergic reactions such as rash or anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like fainting, chest pain, jaundice, or swelling of the face and throat.

Nitrendipin Al is contraindicated in patients with known hypersensitivity to nitrendipine or any component of the formulation, and in individuals with severe hypotension or cardiogenic shock. Caution is also advised for patients with significant hepatic impairment, as drug clearance may be reduced.